Thursday, May 9, 2024

AstraZeneca COVID jab pulled from global markets

 

 

 https://shore-215.blogspot.com/search?q=AstraZeneca
https://shore-215.blogspot.com/2021/03/germany-reports-more-blood-clot-cases.html
https://shore-215.blogspot.com/2021/03/canada-is-pausing-use-of-astrazenecas.html

The hasty authorization of the AstraZeneca COVID jab based on third-party assessments, despite significant contamination issues and manufacturing concerns, undermines Health Canada’s mandate of quality assurance and safety oversight.

No comments:

Post a Comment